Evidence map›Paper›PMID 38900645›Full record

ReviewChembiochem : a European journal of chemical biology2024

New Frontiers in Nonheme Enzymatic Oxyferryl Species.

Jared C Paris, Yuk Hei Cheung, Tao Zhang, Wei-Chen Chang, Pinghua Liu, Yisong Guo

Abstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jared C ParisDepartment of Chemistry, Carnegie Mellon University, 4400 Fifth Ave., Pittsburgh, PA, 15213, USA.ORCID 0000-0001-9932-5208
Yuk Hei CheungDepartment of Chemistry, Boston University, 590 Commonwealth Ave., Boston, MA, 02215, USA.
Tao ZhangDepartment of Chemistry, Boston University, 590 Commonwealth Ave., Boston, MA, 02215, USA.
Wei-Chen ChangDepartment of Chemistry, North Carolina State University, 2620 Yarbrough Dr., Raleigh, NC, 27695, USA.ORCID 0000-0002-2341-9846
Pinghua LiuDepartment of Chemistry, Boston University, 590 Commonwealth Ave., Boston, MA, 02215, USA.ORCID 0000-0002-9768-559X
Yisong GuoDepartment of Chemistry, Carnegie Mellon University, 4400 Fifth Ave., Pittsburgh, PA, 15213, USA.ORCID 0000-0002-4132-3565

Funding

Understanding How Nonheme Iron-Dependent Enzymes Assemble Pharmacophores: Studies of Cyclopropane, Aziridine, and Isonitrile FormationR01GM127588 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Wei-chen Chang · 2018 to 2026
$3.3M
Alkaloid Biosynthetic StudiesR01GM140040 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI LIU, PINGHUA · 2021 to 2024
$1.4M
National Science Foundation CHE-1654060National Science Foundation CHE-2004109NIGMS NIH HHS R01 GM127588NIGMS NIH HHS R01 GM140040NIH HHS R01GM127588NIH HHS R01GM140040
6 · The paper itself

Abstract

Non-heme mononuclear iron dependent (NHM-Fe) enzymes exhibit exceedingly diverse catalytic reactivities. Despite their catalytic versatilities, the mononuclear iron centers in these enzymes show a relatively simple architecture, in which an iron atom is ligated with 2-4 amino acid residues, including histidine, aspartic or glutamic acid. In the past two decades, a common high-valent reactive iron intermediate, the S=2 oxyferryl (Fe(IV)-oxo or Fe(IV)=O) species, has been repeatedly discovered in NHM-Fe enzymes containing a 2-His-Fe or 2-His-1-carboxylate-Fe center. However, for 3-His/4-His-Fe enzymes, no common reactive intermediate has been identified. Recently, we have spectroscopically characterized the first S=1 Fe(IV) intermediate in a 3-His-Fe containing enzyme, OvoA, which catalyzes a novel oxidative carbon-sulfur bond formation. In this review, we summarize the broad reactivities demonstrated by S=2 Fe(IV)-oxo intermediates, the discovery of the first S=1 Fe(IV) intermediate in OvoA and the mechanistic implication of such a discovery, and the intrinsic reactivity differences of the S=2 and the S=1 Fe(IV)-oxo species. Finally, we postulate the possible reasons to utilize an S=1 Fe(IV) species in OvoA and their implications to other 3-His/4-His-Fe enzymes.

Indexed as

IronNonheme Iron ProteinsOxidation-ReductionIronNonheme Iron ProteinsC−H activationFerryl intermediatesNonheme iron enzymesOxidative C−S bond formationSpin state

Identifiers

PMID38900645
PMCPMC11983317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.